NUTX
Nutex Health Inc.
+2.76 (+1.27%)220.09USD44.6K成交股數1.5B市值18.4本益比(近四季)1.8股價營收比-13.6%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 211M-0% | 216M-16% | 268M+240% | 244M+221% | 212M+214% | 258M+270% | 78.8M+26% | 76.1M+29% | 67.5M | 69.7M | 62.7M | 58.9M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | 141M+19% | 91.7M-35% | 155M+607% | 125M+454% | 118M+1065% | 142M+972% | 21.9M+210% | 22.6M+134% | 10.2M | 13.2M | 7.1M | 9.6M |
| 毛利率 | 67.0% | 42.4% | 57.8% | 51.2% | 55.9% | 55.0% | 27.8% | 29.7% | 15.1% | 19.0% | 11.3% | 16.4% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 16.7M | 14.4M | 11.3M | 12.5M | 10.0M | 12.7M | 9.9M | 10.7M | 8.7M | 8.5M | 7.8M | 9.8M |
| 營業利益 | 122M+51% | 81.3M-29% | 130M+1249% | 33.7M+536% | 80.7M+5463% | 114M-537% | 9.7M-1277% | 5.3M-1562% | 1.5M | −26.1M | −821K | −363K |
| 營業利益率 | 57.8% | 37.5% | 48.7% | 13.8% | 38.1% | 44.3% | 12.3% | 7.0% | 2.1% | -37.5% | -1.3% | -0.6% |
| 稅後淨利 | 65.8M+210% | 46.8M-24% | 55.4M-731% | −17.7M+4762% | 21.2M-5929% | 61.7M-295% | −8.8M+59% | −364K-90% | −364K | −31.6M | −5.5M | −3.5M |
| 淨利率 | 31.2% | 21.6% | 20.7% | -7.3% | 10.0% | 23.9% | -11.2% | -0.5% | -0.5% | -45.4% | -8.8% | -5.9% |
| 稀釋 EPS | 9.38+182% | 6.52-41% | 7.76-551% | -2.95+4114% | 3.33-4263% | 11.12-249% | -1.72+38% | -0.07-91% | -0.08 | -7.47 | -1.25 | -0.79 |
| 稀釋股數 | 7.0M | 7.2M | 7.2M | 6.0M | 6.5M | – | 5.1M | 5.0M | 4.8M | – | 4.4M | 657M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 205M | 207M | 166M | 96.7M | 84.7M | 40.6M | 46.9M | 40.8M | 30.0M | 22.0M | 26.8M | 32.8M |
| 應收帳款 | – | – | – | – | 295M | 232M | 62.7M | 60.7M | 61.5M | 58.6M | 53.2M | 50.7M |
| 存貨 | 4.2M | 4.7M | 3.2M | 2.3M | 3.1M | 2.9M | 2.3M | 2.8M | 3.0M | 3.4M | 2.7M | 2.5M |
| 總資產 | 965M | 957M | 965M | 841M | 762M | 655M | 438M | 422M | 404M | 398M | 480M | 436M |
| 有息負債 | 31.1M | 24.3M | 25.6M | 20.5M | 21.7M | 22.5M | 26.8M | 22.4M | 26.3M | 26.3M | 19.3M | 25.1M |
| 總負債 | 457M | 515M | 526M | 504M | 507M | 467M | 359M | 340M | 324M | 319M | 375M | 328M |
| 股東權益 | 394M | 346M | 317M | 235M | 177M | 132M | 60.4M | 62.7M | 63.0M | 61.5M | 89.9M | 92.6M |
| 負債比 | 47.4% | 53.8% | 54.6% | 59.9% | 66.5% | 71.2% | 81.8% | 80.6% | 80.2% | 80.1% | 78.1% | 75.2% |
| 淨現金(現金 − 有息負債) | 174M | 183M | 140M | 76.3M | 63.0M | 18.2M | 20.1M | 18.4M | 3.7M | −4.3M | 7.5M | 7.6M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 75.5M | – | – | 51.0M+1570% | – | – | – | 3.1M | – | – | – |
| 資本支出 | – | 1.2M | – | – | 64K | – | – | – | 733K | – | – | 3.1M |
| 自由現金流 | – | 74.3M | – | – | 50.9M+2096% | – | – | – | 2.3M | – | – | – |
| 折舊攤銷 | 5.3M | 5.5M | 5.0M | 5.2M | 5.1M | – | 5.0M | 4.5M | 4.2M | – | 4.7M | 4.2M |
| 買回庫藏股 | – | 31.7M | – | – | 0.00 | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 34.3% | – | – | 24.0% | – | – | – | 3.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 875M
| Hospital Division | 844M | 96.4% | +88.0% |
|---|---|---|---|
| Population Health Management Division | 31.1M | 3.6% | +0.7% |
產品／服務2025 年度 · 875M
| Hospital Division | 844M | 96.4% | +88.0% |
|---|---|---|---|
| Population Health Management Division | 31.1M | 3.6% | +0.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 875M | +82.4% | 70.8M | 8.1% | 10.48 | 246M |
| FY2024 | 480M | +93.8% | 52.1M | 10.9% | 9.69 | 20.8M |
| FY2023 | 248M | +12.9% | −45.8M | -18.5% | -10.39 | −8.2M |
| FY2022 | 219M | -33.9% | −425M | -193.7% | -100.36 | 36.0M |
| FY2021 | 332M | +21.0% | 133M | 40.0% | 0.22 | 137M |
| FY2020 | 274M | +19954.5% | 106M | 38.7% | 0.18 | 25.5M |
| FY2019 | 1.4M | -0.0% | −7.1M | -520.8% | -1.96 | −4.1M |
| FY2018 | 1.4M | – | −950K | -69.5% | -0.56 | −480K |